Exploratory Antinociceptive and Anti‐Inflammatory Effects of Dittrichia viscosa Extracts: HPLC‐PDA Fingerprinting, Preliminary Acute Tolerability, ADMET Prediction, and Docking‐Based Prioritization
Pain Research and Management · 2026
DOI: 10.1155/prm/7424265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pain Research and Management, 2026. Verfasst von Sara Tlemcani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biotechnology, Environment, Agri-Food, and Health, Faculty of Sciences Dhar El Mahraz, Sidi Mohamed Ben Abdellah University, B.P. 1796 …. Hauptthemen laut MEDLINE: Plant Extracts, Analgesics, Anti-Inflammatory Agents, Asteraceae. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chung Shan Medical University.
Abstract (Originalsprache)
The present exploratory study examined a hydroethanolic extract (HEE) and an ethyl‐acetate‐derived fraction operationally termed the polyphenolic fraction (PF) of Dittrichia viscosa by combining HPLC‐PDA fingerprinting, acute nociception and inflammation models, a 72‐h acute oral tolerability screen of HEE, and in silico prioritization. The HPLC‐PDA fingerprint of HEE contained 31 peaks. Because the available analytical record did not support validated absolute quantification, platform‐exported values are reported only as relative chromatographic abundance. The larger peaks included p‐coumaric acid (7.20%), caffeic acid (5.11%), a putative caffeic acid‐O‐hexoside dimer (4.55%), a putative isorhamnetin‐O‐hexoside (3.57%), a putative hydroxybenzoic acid hexoside (3.25%), and apigenin (3.23%); six annotations were standard‐supported, whereas the remaining assignments were putative. In rats ( n = 5/group), every treatment‐control comparison in the writhing and formalin models was significant in the summary‐statistic Dunnett reanalysis (adjusted p < 0.0001). PF at 100 mg/kg produced 59.5% writhing inhibition and mean differences versus vehicle of −38.46 s (95% CI −40.42 to −36.50) and −23.00 s (95% CI −24.45 to −21.55) in the early and late formalin phases, respectively. In the carrageenan model, significant differences occurred mainly at 6 h; PF at 100 mg/kg differed from vehicle by −0.24 cm (95% CI −0.34 to −0.14; adjusted p = 0.0002). Percentage inhibition values are descriptive. No mortality or overt clinical signs were observed after HEE doses up to 4000 mg/kg during 72 h, which constitutes preliminary acute tolerability evidence for HEE only. Predicted ADMET outputs and AutoDock Vina scores prioritized candidate ligands but do not establish exposure, safety, target inhibition, or causal contribution to the extract‐level effects. These exploratory findings support further preclinical investigation, subject to chemical confirmation, raw‐data‐based longitudinal statistics, direct target assays, and guideline‐compliant safety studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biotechnology, Environment, Agri-Food, and Health, Faculty of Sciences Dhar El Mahraz, Sidi Mohamed Ben Abdellah University, B.P. 1796 Atlas, Fez, 30000, Morocco, usmba.ac.ma.
- Laboratory of Engineering, Electrochemistry, Modeling and Environment, Faculty of Sciences Dhar El Mahraz, Sidi Mohamed Ben Abdellah University, B.P. 1796 Atlas, Fez, 30000, Morocco, usmba.ac.ma.
- Laboratory of Applied Chemistry and Environment, Faculty of Sciences, Mohammed First University, BP 717, 60000, Oujda, Morocco.
- Laboratory of Bioresources, Biotechnology, and Sustainable Development, Faculty of Sciences, Mohammed First University, BV Mohammed VI BP 717, 60000, Oujda, Morocco.
- Department of Medical Applied Chemistry, Chung Shan Medical University, 402, Taichung, Taiwan, csmu.edu.tw.
- Department of Chemistry, Laboratory of Engineering, Organometallic and Molecular Materials and Environment, Faculty of Sciences Dhar El Mahraz, Sidi Mohamed Ben Abdellah University, Fez, Morocco, usmba.ac.ma.
ORCID-Profile: Abdessadek Essadek, Chin-Hung Lai
Förderung
- Chung Shan Medical University
Zitieren
APA
Tlemcani, S., Khibech, O., Lahkimi, A., Essadek, A., Lai, C. H., Hmamou, A., Idrissi, A. M., Aichouch, M., Elrherabi, A., Bouhrim, M., & Bekkari, H. (2026). Exploratory Antinociceptive and Anti‐Inflammatory Effects of Dittrichia viscosa Extracts: HPLC‐PDA Fingerprinting, Preliminary Acute Tolerability, ADMET Prediction, and Docking‐Based Prioritization. Pain Research and Management. https://doi.org/10.1155/prm/7424265
Vancouver
Tlemcani S, Khibech O, Lahkimi A, Essadek A, Lai CH, Hmamou A, et al. Exploratory Antinociceptive and Anti‐Inflammatory Effects of Dittrichia viscosa Extracts: HPLC‐PDA Fingerprinting, Preliminary Acute Tolerability, ADMET Prediction, and Docking‐Based Prioritization. Pain Research and Management. 2026. doi:10.1155/prm/7424265
BibTeX
@article{Tlemcani2026,
author = {Tlemcani, Sara and Khibech, Oussama and Lahkimi, Amal and Essadek, Abdessadek and Lai, Chin-Hung and Hmamou, Anouar and Idrissi, Amine Mounadi and Aichouch, Maryem and Elrherabi, Amal and Bouhrim, Mohamed and Bekkari, Hicham},
title = {Exploratory Antinociceptive and Anti‐Inflammatory Effects of Dittrichia viscosa Extracts: HPLC‐PDA Fingerprinting, Preliminary Acute Tolerability, ADMET Prediction, and Docking‐Based Prioritization},
journal = {Pain Research and Management},
year = {2026},
doi = {10.1155/prm/7424265}
}
EUVIMED